The cardioprotective role of beta-blockers in patients with diabetes mellitus.
This paper reviews the role of beta-blockers in the prevention of cardiovascular morbidity and mortality in patients with diabetes mellitus. There is good evidence from randomized controlled trials that beta-blockers, in particular the lipophilic agents, substantially reduce cardiovascular mortality...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2002
|
| _version_ | 1797099559905656832 |
|---|---|
| author | Landray, M Toescu, V Kendall, M |
| author_facet | Landray, M Toescu, V Kendall, M |
| author_sort | Landray, M |
| collection | OXFORD |
| description | This paper reviews the role of beta-blockers in the prevention of cardiovascular morbidity and mortality in patients with diabetes mellitus. There is good evidence from randomized controlled trials that beta-blockers, in particular the lipophilic agents, substantially reduce cardiovascular mortality and morbidity. However, hitherto beta-blockers have been underused in diabetic patients, perhaps because of perceived risks of beta-blocker therapy. Reappraisal of the evidence suggests that the traditional reluctance to use beta-blockers in this group is based on fears of adverse effects that are largely unfounded. |
| first_indexed | 2024-03-07T05:25:31Z |
| format | Journal article |
| id | oxford-uuid:e06961bf-3a28-41f3-914b-f9f707a963d9 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:25:31Z |
| publishDate | 2002 |
| record_format | dspace |
| spelling | oxford-uuid:e06961bf-3a28-41f3-914b-f9f707a963d92022-03-27T09:47:01ZThe cardioprotective role of beta-blockers in patients with diabetes mellitus.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e06961bf-3a28-41f3-914b-f9f707a963d9EnglishSymplectic Elements at Oxford2002Landray, MToescu, VKendall, MThis paper reviews the role of beta-blockers in the prevention of cardiovascular morbidity and mortality in patients with diabetes mellitus. There is good evidence from randomized controlled trials that beta-blockers, in particular the lipophilic agents, substantially reduce cardiovascular mortality and morbidity. However, hitherto beta-blockers have been underused in diabetic patients, perhaps because of perceived risks of beta-blocker therapy. Reappraisal of the evidence suggests that the traditional reluctance to use beta-blockers in this group is based on fears of adverse effects that are largely unfounded. |
| spellingShingle | Landray, M Toescu, V Kendall, M The cardioprotective role of beta-blockers in patients with diabetes mellitus. |
| title | The cardioprotective role of beta-blockers in patients with diabetes mellitus. |
| title_full | The cardioprotective role of beta-blockers in patients with diabetes mellitus. |
| title_fullStr | The cardioprotective role of beta-blockers in patients with diabetes mellitus. |
| title_full_unstemmed | The cardioprotective role of beta-blockers in patients with diabetes mellitus. |
| title_short | The cardioprotective role of beta-blockers in patients with diabetes mellitus. |
| title_sort | cardioprotective role of beta blockers in patients with diabetes mellitus |
| work_keys_str_mv | AT landraym thecardioprotectiveroleofbetablockersinpatientswithdiabetesmellitus AT toescuv thecardioprotectiveroleofbetablockersinpatientswithdiabetesmellitus AT kendallm thecardioprotectiveroleofbetablockersinpatientswithdiabetesmellitus AT landraym cardioprotectiveroleofbetablockersinpatientswithdiabetesmellitus AT toescuv cardioprotectiveroleofbetablockersinpatientswithdiabetesmellitus AT kendallm cardioprotectiveroleofbetablockersinpatientswithdiabetesmellitus |